Effect of Bodhivriksha Kashaya Ghana Vati on Vatarakta

A Comparative Clinical Study of Bodhivriksha Kashaya Ghana Vati and Febuxostat in the Cases of Vatarakta vis a vis Gout - No

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/053250

Enrollment

100

Registered

2023-05-30

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to participate in the trial Patients fulfilling the 2015 ACR EULAR Gout classification criteria and classical signs and symptoms mentioned Patients between the age group of 25-55 years of either sex Patients having serum uric acid >7mg/dl in males and >6mg/dl in females with or any associate features like joint pain and Inflammation

Exclusion criteria

Exclusion criteria: Patients unwilling to participate in the trial Patients below the age of 25 years and above 55 years of age Patients suffering from chronic respiratory cardiac hepatic and hormonal disorder Mentally unstable and substance abuse patients Patients of Chronic Vatarakta who have developed gross joint deformity and associated with complication Pregnant and lactating women Patients about to undergo surgical intervention

Design outcomes

Primary

Measure	Time frame
Serum Uric Acid CRP ESR Routine Blood Investigation LFT RFT CBC Timepoint: outcome will be assessed at every 4 weeks for 3 months	—

Secondary

Measure	Time frame
Ama Strenght Assesment WHO QOL BREF Assesment Deha and Manas prakriti assessmentTimepoint: 3 Months Before and after trial intervention	—

Countries

India

Contacts

Public ContactDr Ajai Kumar Pandey

Banaras Hindu University Varanasi

drajaipandey@gmail.com9452827885

Outcome results